SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-022146
Filing Date
2014-04-11
Accepted
2014-04-11 16:32:32
Documents
8
Period of Report
2014-05-22
Effectiveness Date
2014-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A v370500_def14a.htm DEF 14A 1053048
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_anipharma-black.jpg GRAPHIC 3772
4 GRAPHIC sig_charlotte-arnold.jpg GRAPHIC 1935
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC sig_arthur-przybyl.jpg GRAPHIC 5344
7 GRAPHIC v370500_proxycard1.jpg GRAPHIC 222424
8 GRAPHIC v370500_proxycard2.jpg GRAPHIC 187257
  Complete submission text file 0001144204-14-022146.txt   1635131
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 14760430
SIC: 2834 Pharmaceutical Preparations